An Overview of Peptides and Peptide Pools for Antigen-Specific Stimulation in T-Cell Assays

K Schnatbaum, P Holenya, S Pfeil, M Drosch… - Handbook of ELISPOT …, 2024 - Springer
The analysis of antigen-specific T-cell responses has become routine in many laboratories.
Functional T-cell assays like enzyme-linked-immuno-spot (ELISPOT), which depend on …

Genetic Signature of Human Pancreatic Cancer and Personalized Targeting

SJ Reshkin, RA Cardone, T Koltai - Cells, 2024 - mdpi.com
Pancreatic cancer is a highly lethal disease with a 5-year survival rate of around 11–12%.
Surgery, being the treatment of choice, is only possible in 20% of symptomatic patients. The …

Altering relative metal-binding affinities in multifunctional Metallochaperones for mutant p53 reactivation

K Kwan, O Castro-Sandoval, B Ma, D Martelino… - Journal of Inorganic …, 2024 - Elsevier
The p53 protein plays a major role in cancer prevention, and over 50% of cancer diagnoses
can be attributed to p53 malfunction. p53 incorporates a structural Zn site that is required for …

[HTML][HTML] Amyloid aggregates induced by the p53-R280T mutation lead to loss of p53 function in nasopharyngeal carcinoma

J Li, M Guo, L Chen, Z Chen, Y Fu, Y Chen - Cell Death & Disease, 2024 - nature.com
Nasopharyngeal carcinoma (NPC) is a malignant tumor that is highly prevalent in Southeast
Asia, especially in South China. The pathogenesis of NPC is complex, and genetic …

Chb-M′, an Inhibitor of the RUNX Family Binding to DNA, Induces Apoptosis in p53-Mutated Non-Small Cell Lung Cancer and Inhibits Tumor Growth and …

Y Hirose, S Sato, K Hashiya, M Ooga… - Journal of Medicinal …, 2024 - ACS Publications
Runt-related transcription factor (RUNX) proteins are considered to play various roles in
cancer. Here, we evaluated the anticancer activity of Chb-M′, a compound that specifically …

Characterization on the oncogenic effect of the missense mutations of p53 via machine learning

Q Pan, S Portelli, TB Nguyen… - Briefings in …, 2024 - academic.oup.com
Dysfunctions caused by missense mutations in the tumour suppressor p53 have been
extensively shown to be a leading driver of many cancers. Unfortunately, it is time …

[HTML][HTML] Targeting p53 misfolding conundrum by stabilizing agents and their analogs in breast cancer therapy: a comprehensive computational analysis

BU Haq, H Qayoom, S Sofi, N Jan, A Shabir… - Frontiers in …, 2024 - frontiersin.org
Cancer continues to be a major global public health concern and one of the foremost causes
of death. Delays in the diagnosis and cure may cause an increase in advanced stage …

Rescue of p53 functions by in vitro‐transcribed mRNA impedes the growth of high‐grade serous ovarian cancer

M Raab, I Kostova, S Peña‐Llopis, D Fietz… - Cancer …, 2024 - Wiley Online Library
Background The cellular tumor protein p53 (TP53) is a tumor suppressor gene that is
frequently mutated in human cancers. Among various cancer types, the very aggressive high …

Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets

J Gong, S Hu, Q Shan, J Qin, N Han… - … Advances in Medical …, 2024 - journals.sagepub.com
Background: Bone metastasis (BM) seriously affects the quality of life and reduces the
survival time of patients with non-small-cell lung cancer (NSCLC). The genomic …

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability

YQ Lü, T Cho, S Mukherjee, CF Suarez… - Molecular Systems …, 2024 - embopress.org
Abstract Tumor suppressor p53 (TP53) is frequently mutated in cancer, often resulting not
only in loss of its tumor-suppressive function but also acquisition of dominant-negative and …